GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.

Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Ware tallied 16 points (7-17 FG, 1-4 3Pt, 1-2 FT), seven rebounds, one assist, two blocks and two steals over 28 minutes in Friday's 114-109 preseason win over the Grizzlies. Ware saw extended ...

Now, with a substantial collection of products, he’s celebrating the grand opening of his new storefront, Ware to Wear. Located at 777 Culver Road, the store features a variety of vintage pieces ...

GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio, and is now suing the biotechnology company for infringement. At issue is the work of a team ...

GSK is also seeking damages to compensate for the alleged infringement as well as a “compulsory ongoing licensing fee” for the claimed technologies. “Moderna has reaped billions of dollars in revenue ...

Still, it can become pressing enough if preventative strategies are not put in place. Dr. Leah Smith and Laarni San Juan are shingles advocates from GSK, an international pharmaceutical company. These ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...

Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA vaccine-delivery technology, the company said in a pair of federal lawsuits.